FIRST LICENSED MELATONIN FOR SLEEP DISORDERS IN CHILDREN AND ADOLESCENTS WITH ADHD LAUNCHES IN UK
Swedish Pharmaceutical Company, AGB-Pharma, has recently launched Adaflex, the UK’s first melatonin product for insomnia in children and adolescents aged 6-17 years old with ADHD (where sleep hygiene measures have been insufficient). Melatonin has long been understood as an effective and safe treatment for ...
Source: pharmiweb.com